GSI Capital Advisors LLC Takes $3.61 Million Position in Sabra Healthcare REIT, Inc. $SBRA

GSI Capital Advisors LLC purchased a new stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) in the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 190,814 shares of the real estate investment trust’s stock, valued at approximately $3,614,000. Sabra Healthcare REIT accounts for 2.0% of GSI Capital Advisors LLC’s holdings, making the stock its 25th largest position.

Several other hedge funds have also recently bought and sold shares of the company. Nuveen LLC lifted its position in Sabra Healthcare REIT by 28.6% in the 4th quarter. Nuveen LLC now owns 7,303,254 shares of the real estate investment trust’s stock valued at $138,324,000 after purchasing an additional 1,625,072 shares during the last quarter. Centersquare Investment Management LLC bought a new stake in Sabra Healthcare REIT in the 4th quarter valued at about $50,276,000. Empowered Funds LLC bought a new stake in Sabra Healthcare REIT in the 4th quarter valued at about $3,129,000. Inceptionr LLC lifted its position in Sabra Healthcare REIT by 53.5% in the 4th quarter. Inceptionr LLC now owns 28,722 shares of the real estate investment trust’s stock valued at $544,000 after purchasing an additional 10,014 shares during the last quarter. Finally, Cerity Partners LLC lifted its position in Sabra Healthcare REIT by 82.7% in the 4th quarter. Cerity Partners LLC now owns 53,146 shares of the real estate investment trust’s stock valued at $1,007,000 after purchasing an additional 24,055 shares during the last quarter. 99.40% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

SBRA has been the topic of several recent research reports. Truist Financial lifted their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a research report on Friday, March 13th. Citizens Jmp lifted their price objective on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a research report on Wednesday, February 18th. Wall Street Zen upgraded shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Monday, May 18th. Weiss Ratings downgraded shares of Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a research report on Thursday, June 4th. Finally, Citigroup lifted their price objective on shares of Sabra Healthcare REIT from $21.00 to $24.00 and gave the company a “buy” rating in a research report on Wednesday, February 18th. Five equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $22.40.

Sabra Healthcare REIT Stock Performance

Shares of SBRA opened at $18.49 on Friday. The firm’s 50 day moving average is $20.08 and its 200-day moving average is $19.69. The stock has a market capitalization of $4.66 billion, a P/E ratio of 29.35, a P/E/G ratio of 1.40 and a beta of 0.64. The company has a debt-to-equity ratio of 0.96, a current ratio of 4.72 and a quick ratio of 4.72. Sabra Healthcare REIT, Inc. has a 12-month low of $17.17 and a 12-month high of $21.28.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.16. The company had revenue of $211.74 million for the quarter, compared to analysts’ expectations of $209.20 million. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The business’s revenue was up 20.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.37 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Equities research analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.51 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were paid a $0.30 dividend. The ex-dividend date of this dividend was Friday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.5%. Sabra Healthcare REIT’s payout ratio is currently 190.48%.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.